Support for fecal testing in familial colorectal cancer screening

Fecal immunochemical tests (FIT) may be as effective as colonoscopies when it comes to detecting colorectal cancer among first-degree relatives of patients with colorectal cancer, according to a new study in Gastroenterology, the official journal of the American Gastroenterological Association.

"In our study, repeat FIT screening detected all colorectal cancers in asymptomatic first-degree relatives of patients with colorectal ," said lead study authors Enrique Quintero, MD, PhD, and Marta Carrillo, MD, from Hospital Universitario de Canarias, Tenerife, Spain. "These findings suggest that FIT screening should potentially be considered for familial screening, especially in populations where colonoscopy capacity is limited and/or compliance with colonoscopy is a concern."

Researchers conducted a prospective to compare the efficacy of repeated FITs and colonoscopy in detecting advanced tumors in family members of patients with colorectal cancer. The study included 1,918 first-degree relatives of patients with colorectal cancer, who were randomly split into two groups to receive either a single colonoscopy examination or three FITs—one a year for three years.

Repeated FIT screening detected all and 61 percent of advanced adenomas, thus proving equivalent to one-time colonoscopy screening in terms of diagnostic yield and tumor staging. However, colonoscopy was superior to the FIT strategy for the detection of non-advanced adenomas.

"There is evidence showing underutilization of colonoscopy at the recommended intervals among asymptomatic first-degree relatives of patients. FIT could potentially offer a less invasive option for these patients," added the authors.

The usefulness of FIT screening as an alternative to colonoscopy in the familial risk population will ultimately depend on the capacity of FIT to improve screening uptake.

First-degree relatives of with colorectal cancer are at high risk of developing colorectal cancer. Current practice guidelines recommend that subjects with familial colorectal cancer be subject to more intensive screening strategies than the average-risk population. For individuals with first-degree relatives with colorectal cancer, the current guideline recommends colonoscopy every five years, starting at the age of 40 or ten years before the youngest case in the immediate family.

This was the first randomized trial to compare with FIT screening in familial colorectal cancer.

Explore further

Fecal blood test may save more lives than colonoscopy

More information: Quintero, Enrique et al., Equivalency of Fecal Immunochemical Tests and Colonoscopy in Familial Colorectal Cancer Screening, Gastroenterology, Volume 147, Issue 5, 1021-1030.e1. … (14)01000-2/abstract
Journal information: Gastroenterology

Citation: Support for fecal testing in familial colorectal cancer screening (2014, October 29) retrieved 13 June 2021 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors

User comments